References
- Bonraassat E, Bonmassar A, Vadlamudi S, Goldin A. Immunological alteration of leukemic cells in vivo after treatment with an antitumor drug. Proc Natl Acad Sci (USA) 1970; 66: 1089–1095.
- Houchens DP, Bonmassar E, Gaston MR, Kende M, Goldin A. Drug-mediated immunogenic changes of virus-induced leukemia in vivo. Cancer Res 1976; 36: 1347–1352.
- Contessa AR, Bonmassar A, Gianpietri A, Circolo A, Goldin A, Fioretti MC. In vitro generation of a highly immunogenic subline of L1210 leukemia following exposure to 5-(3,3-dimethyl-l-triazeno)-imidazole-4-carboxamide. Cancer Res 1981; 41: 2476–2482.
- Nardelli B, Contessa AR, Romani L, Sava G, Nisi C. Immunogenic changes of murine lymphoma cells following in vitro treatment with aryltriazene derivatives. Cancer Immunol Immunother 1984; 16: 157–161.
- Puccetti P, Romani L, Fioretti MC. Chemical xenogenization of tumor cells. Trends Pharmacol Sci 1985; 6: 485–487.
- Giampietri A, Fioretti MC, Goldin A, Bonmassar E. Drug- mediated antigenic changes in murine leukemic cells: antagonistic effect of quinacrine, an antimutagenic compound. J Natl Cancer Inst 1980; 64: 297–301.
- Romani L, Puccetti P, Fioretti MC, Mage MG. Humoral response against murine lymphoma cells xenogenized by drug treatment in vivo. Int J Cancer 1985; 36: 225–231.
- Romani L, Grohmann U, Fazioli F, Puccetti P, Mage MG, Fioretti MC. Cell-mediated immunity to chemically xenogenized tumors. I. Inhibition by specific antisera and H-2 association of the novel antigens. Cancer Immunol Immunother 1988; 26: 48–54.
- Grohmann U, Puccetti P, Romani L, et al. Immunogenic tumor variants induced by drug treatment of the L5178Y lymphoma: search for serologically defined antigens at the clonal level. Int J Cancer 1992; 52: 372–377.
- Riccardi C, Fioretti MC, Giampietri A, Puccetti P, Goldin A, Bonmassar E. Growth inhibition of normal or drug-treated lymphoma cells in lethally irradiated mice. J Natl Cancer Inst. 1978; 60: 1083–1090.
- Franchi A, Papa G, D’Atri S, Piccioni D, Masi M, Bonmassar E. Cytotoxic effects of dacarbazine in patients with acute myelogenous leukemia: a pilot study. Haematologica 1992; 77: 146–150.
- Trinchieri G, Santoli D. Antiviral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis. J Exp Med 1978; 147: 1313–1344.
- Reiter Z. Interferon: a major regulator of natural killer cell-mediated cytotoxicity. J Interferon Res 1993; 13: 247–257.
- Lozzio CB, Lozzio BB. Properties and usefulness of the original K562 human myelogenous leukemia cell line. Leukemia Res 1979; 3: 363–370.
- Morten JEN, Margison GP. Increased O6-alkylguanine alkyltransferase activity in Chinese hamster V79 cells following selection with chloroethylating agents. Carcinogenesis 1988; 9: 45–49
- Walker MC, Masters JRW, Margison GP. O6-alkylguanine-DNA-alkyltransferase activity and nitrosourea sensitivity in human cancer cell lines. Br J Cancer 1992; 66: 840–843.
- Catapano CV, Broggini M, Erba E, et al. In vitro and in vivo methazolastone induced DNA damage and repair in L1210 leukemia sensitive and resistant to chloroethylnitrosoureas. Cancer Res 1987; 47: 4884–4889.
- D’Atri S, Tricarico M, Margison GP, et al. Antigenic changes of cancer cells following interaction with antitumor agents. In: Proceedings of Pezcoller Foundation Symposia on Drug Resistance: Mechanisms and Reversal. (CIC Edizioni Internazionali, Rome, Italy) 1989; 271–287.
- Storkus WJ, Salter RD, Cresswell P, Dawson JR. Peptide-induced modulation of target cell sensitivity to natural killing. J Immunol 1992; 149: 1185–1190.
- D’Atri S, Marini S, Tentori L, Tricarico M, Fuggetta MP, Bonmassar E. Drug-mediated increase of susceptibility of human lung cancer to NK or LAK effector cells. Immuno-pharmacology 1991; 21: 199–210.
- Litwin V, Gumperz J, Parham P, Phillips JH, Lanier L. Specificity of HLA class I antigen recognition by human NK clones: evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell type. J Exp Med 1993; 178: 1321–1336.
- Fioretti MC, Bianchi R, Romani L, Bonmassar E. Drug-induced immunogenic changes of murine leukemia cells: dissociation of onset of resistance and emergence of novel immunogenicity. J Natl Cancer Inst 1983; 71: 1247–1251.
- Storkus WJ, Howell DN, Salter RD, Dawson JR, Cresswell P. NK susceptibility varies inversely with target cell class I HLA antigen expression. J Immunol 1987; 138: 1657–1659.